Dec 10, 2009
StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH Guidelines
StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009